4996.JP
Kumiai Chemical cuts fiscal 2026 net profit forecast to 4 billion yen on generic entry impairment
Kumiai Chemical Industry said on the 11th that it has revised down its consolidated net profit forecast for the fiscal year ending October 2026 to 4 billion yen from the previous 6.4 billion yen. It had previously expected a profit increase, but now anticipates an 8.7% decline from the prior year. In addition to an inventory valuation loss tied to generic competition for its overseas herbicide Axeev, special losses including impairment of fixed assets and restructuring costs are also weighing on net profit. The operating profit forecast was cut to 2.7 billion yen from the previous 7.2 billion yen. Meanwhile, the sales forecast was raised to 175 billion yen from the previous 162 billion yen on higher sales volumes.